Literature DB >> 20122715

Early-life chlamydial lung infection enhances allergic airways disease through age-dependent differences in immunopathology.

Jay C Horvat1, Malcolm R Starkey, Richard Y Kim, Simon Phipps, Peter G Gibson, Kenneth W Beagley, Paul S Foster, Philip M Hansbro.   

Abstract

BACKGROUND: Asthma typically originates in early-life, and the impact of infection during immunologic maturation is a critical factor in disease pathogenesis. The progression of aberrant T(H)2 cell responses and disease development has been attributed to a lack of infections. However, exposure to specific pathogens such as Chlamydia may alter immunologic programming and predispose to asthma.
OBJECTIVE: To investigate the effects of chlamydial infection at different ages on allergic airways disease in later life.
METHODS: Neonatal, infant, or adult BALB/c mice were infected and 6 weeks later were sensitized and subsequently challenged with ovalbumin. Hallmark features of allergic airways disease were compared with uninfected allergic and nonallergic controls.
RESULTS: Early-life (neonatal and infant) but not adult chlamydial infection enhanced the development of hallmark features of asthma in ovalbumin-induced allergic airways disease. Notably early-life infection increased mucus-secreting cell numbers, IL-13 expression, and airway hyperresponsiveness. Neonatal infection attenuated eosinophil influx and ovalbumin-specific T(H)2 cytokine release and numbers of activated myeloid dendritic cells (DCs) in lymph nodes. By contrast, infant infection augmented features of allergic inflammation with increased airway eosinophils, T(H)2 cytokine, and DC responses. Both neonatal and infant infection increased systemic DC-induced IL-13 release from CD4(+) T cells. The timing of infection had significant effects on lung structure because neonatal but not infant or adult infection induced increases in alveolar diameter.
CONCLUSION: Early-life respiratory chlamydial infections modulate immune responses, alter lung function and structure, and enhance the severity of allergic airways disease in later life.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20122715     DOI: 10.1016/j.jaci.2009.10.018

Source DB:  PubMed          Journal:  J Allergy Clin Immunol        ISSN: 0091-6749            Impact factor:   10.793


  33 in total

1.  Immune responses to self-antigens in asthma patients: clinical and immunopathological implications.

Authors:  Michael Liu; Vijay Subramanian; Chandrika Christie; Mario Castro; Thallachallour Mohanakumar
Journal:  Hum Immunol       Date:  2012-02-17       Impact factor: 2.850

2.  Fibulin-1 regulates the pathogenesis of tissue remodeling in respiratory diseases.

Authors:  Gang Liu; Marion A Cooley; Andrew G Jarnicki; Alan C-Y Hsu; Prema M Nair; Tatt Jhong Haw; Michael Fricker; Shaan L Gellatly; Richard Y Kim; Mark D Inman; Gavin Tjin; Peter A B Wark; Marjorie M Walker; Jay C Horvat; Brian G Oliver; W Scott Argraves; Darryl A Knight; Janette K Burgess; Philip M Hansbro
Journal:  JCI Insight       Date:  2016-06-16

Review 3.  Neonatal immunology: responses to pathogenic microorganisms and epigenetics reveal an "immunodiverse" developmental state.

Authors:  Becky Adkins
Journal:  Immunol Res       Date:  2013-12       Impact factor: 2.829

Review 4.  Role of dendritic cells: a step forward for the hygiene hypothesis.

Authors:  Xi Yang; Xiaoling Gao
Journal:  Cell Mol Immunol       Date:  2010-11-08       Impact factor: 11.530

5.  IL-22 and its receptors are increased in human and experimental COPD and contribute to pathogenesis.

Authors:  Malcolm R Starkey; Maximilian W Plank; Paolo Casolari; Alberto Papi; Stelios Pavlidis; Yike Guo; Guy J M Cameron; Tatt Jhong Haw; Anthony Tam; Ma'en Obiedat; Chantal Donovan; Nicole G Hansbro; Duc H Nguyen; Prema Mono Nair; Richard Y Kim; Jay C Horvat; Gerard E Kaiko; Scott K Durum; Peter A Wark; Don D Sin; Gaetano Caramori; Ian M Adcock; Paul S Foster; Philip M Hansbro
Journal:  Eur Respir J       Date:  2019-07-18       Impact factor: 16.671

Review 6.  Cytokine/anti-cytokine therapy - novel treatments for asthma?

Authors:  Philip M Hansbro; Gerard E Kaiko; Paul S Foster
Journal:  Br J Pharmacol       Date:  2011-05       Impact factor: 8.739

7.  A new short-term mouse model of chronic obstructive pulmonary disease identifies a role for mast cell tryptase in pathogenesis.

Authors:  Emma L Beckett; Richard L Stevens; Andrew G Jarnicki; Richard Y Kim; Irwan Hanish; Nicole G Hansbro; Andrew Deane; Simon Keely; Jay C Horvat; Ming Yang; Brian G Oliver; Nico van Rooijen; Mark D Inman; Roberto Adachi; Roy J Soberman; Sahar Hamadi; Peter A Wark; Paul S Foster; Philip M Hansbro
Journal:  J Allergy Clin Immunol       Date:  2013-02-04       Impact factor: 10.793

8.  Tumor necrosis factor-related apoptosis-inducing ligand translates neonatal respiratory infection into chronic lung disease.

Authors:  M R Starkey; D H Nguyen; A T Essilfie; R Y Kim; L M Hatchwell; A M Collison; H Yagita; P S Foster; J C Horvat; J Mattes; P M Hansbro
Journal:  Mucosal Immunol       Date:  2013-09-18       Impact factor: 7.313

9.  Perinatal factors in neonatal and pediatric lung diseases.

Authors:  Rodney D Britt; Arij Faksh; Elizabeth Vogel; Richard J Martin; Christina M Pabelick; Y S Prakash
Journal:  Expert Rev Respir Med       Date:  2013-10-03       Impact factor: 3.772

10.  Severity of allergic airway disease due to house dust mite allergen is not increased after clinical recovery of lung infection with Chlamydia pneumoniae in mice.

Authors:  Pavel Dutow; Sandra Lingner; Robert Laudeley; Silke Glage; Heinz-Gerd Hoymann; Anna-Maria Dittrich; Beate Fehlhaber; Meike Müller; Armin Braun; Andreas Klos
Journal:  Infect Immun       Date:  2013-07-01       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.